Microglial amyloid-β1-40 phagocytosis dysfunction is caused by high-mobility group box protein-1: Implications for the pathological progression of Alzheimer's disease

International Journal of Alzheimer's Disease

Volumn , Issue , 2012, Pages

  Takata, Kazuyuki ^a   Takada, Tetsuya ^a   Ito, Aina ^a   Asai, Mayo ^a   Tawa, Manami ^a   Saito, Yuki ^a   Ashihara, Eishi ^a,b   Tomimoto, Hidekazu ^c   Kitamura, Yoshihisa ^a   Shimohama, Shun ^d  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c MIE UNIVERSITY   (Japan)

^d SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; HIGH MOBILITY GROUP B1 PROTEIN;

AGED; ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CLEARANCE; CYTOPLASM; DISEASE COURSE; HUMAN; HUMAN TISSUE; MICROGLIA; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; SENILE PLAQUE;

EID: 84862288751     PISSN: None     EISSN: 20900252     Source Type: Journal    
DOI: 10.1155/2012/685739     Document Type: Article

References (56)

1. Selkoe D. J., Alzheimer's disease is a synaptic failure Science 2002 298 5594 789 791 (Pubitemid 35231524)
2. Gtz J., Chen F., Van Dorpe J., Nitsch R. M., Formation of neurofibrillary tangles in P301L tau transgenic mice induced by A 42 fibrils Science 2001 293 5534 1491 1495 (Pubitemid 32807681)
3. Lewis J., Dickson D. W., Lin W. L., Chisholm L., Corral A., Jones G., Yen S. H., Sahara N., Skipper L., Yager D., Eckman C., Hardy J., Hutton M., McGowan E., Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP Science 2001 293 5534 1487 1491 (Pubitemid 32801551)
4. Takata K., Kitamura Y., Nakata Y., Matsuoka Y., Tomimoto H., Taniguchi T., Shimohama S., Involvement of WAVE accumulation in A /APP pathology-dependent tangle modification in Alzheimer's disease American Journal of Pathology 2009 175 1 17 24
5. Bard F., Cannon C., Barbour R., Burke R. L., Games D., Grajeda H., Guido T., Hu K., Huang J., Johnson-Wood K., Khan K., Kholodenko D., Lee M., Lieberburg I., Motter R., Nguyen M., Soriano F., Vasquez N., Weiss K., Welch B., Seubert P., Schenk D., Yednock T., Peripherally administered antibodies against amyloid -peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease Nature Medicine 2000 6 8 916 919 (Pubitemid 30644751)
6. Dodart J. C., Bales K. R., Gannon K. S., Greene S. J., DeMattos R. B., Mathis C., DeLong C. A., Wu S., Wu X., Holtzman D. M., Paul S. M., Immunization reverses memory deficits without reducing brain A burden in Alzheimer's disease model Nature Neuroscience 2002 5 5 452 457 (Pubitemid 34454251)
7. Janus C., Pearson J., McLaurin J., Mathews P. M., Jiang Y., Schmidt S. D., Chishti M. A., Horne P., Heslin D., French J., Mount H. T. J., Nixon R. A., Mercken M., Bergeron C., Fraser P. E., St George-Hyslop P., Westaway D., A peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease Nature 2000 408 6815 979 982 (Pubitemid 32101644)
8. Morgan D., Diamond D. M., Gottschall P. E., Ugen K. E., Dickey C., Hardy J., Duff K., Jantzen P., DiCarlo G., Wilcock D., Connor K., Hatcher J., Hope C., Gordon M., Arendash G. W., A peptide vaccination prevents memory loss in an animal model of Alzheimer's disease Nature 2000 408 6815 982 985 (Pubitemid 32101645)
9. Schenk D., Barbour R., Dunn W., Gordon G., Grajeda H., Guldo T., Hu K., Huang J., Johnson-Wood K., Khan K., Kholodenko D., Lee M., Liao Z., Lieberburg I., Motter R., Mutter L., Soriano F., Shopp G., Vasquez N., Vandevert C., Walker S., Wogulis M., Yednock T., Games D., Seubert P., Immunization with amyloid- attenuates Alzheimer disease-like pathology in the PDAPP mouse Nature 1999 400 6740 173 177 (Pubitemid 29327547)
10. Hock C., Konietzko U., Streffer J. R., Tracy J., Signorell A., Mller-Tillmanns B., Lemke U., Henke K., Moritz E., Garcia E., Wollmer M. A., Umbricht D., De Quervain D. J. F., Hofmann M., Maddalena A., Papassotiropoulos A., Nitsch R. M., Antibodies against -amyloid slow cognitive decline in Alzheimer's disease Neuron 2003 38 4 547 554 (Pubitemid 36645030)
11. Hardy J., Selkoe D. J., The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics Science 2002 297 5580 353 356 (Pubitemid 34790756)
12. Wiltfang J., Esselmann H., Bibl M., Smirnov A., Otto M., Paul S., Schmidt B., Klafki H. W., Maler M., Dyrks T., Bienert M., Beyermann M., Rther E., Kornhuber J., Highly conserved and disease-specific patterns of carboxyterminally truncated A peptides 1-37/38/39 in addition to 1-40/42 in Alzheimer's disease and in patients with chronic neuroinflammation Journal of Neurochemistry 2002 81 3 481 496 (Pubitemid 34809327)
13. Iwatsubo T., Odaka A., Suzuki N., Mizusawa H., Nukina N., Ihara Y., Visualization of A 42(43) and A 40 in senile plaques with end-specific A monoclonals: evidence that an initially deposited species is A 42(43) Neuron 1994 13 1 45 53
14. Jarrett J. T., Berger E. P., Lansbury P. T. Jr., The carboxy terminus of the amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease Biochemistry 1993 32 18 4693 4697 (Pubitemid 23162022)
15. Dahlgren K. N., Manelli A. M., Blaine Stine W., Baker L. K., Krafft G. A., Ladu M. J., Oligomeric and fibrillar species of amyloid- peptides differentially affect neuronal viability Journal of Biological Chemistry 2002 277 35 32046 32053 (Pubitemid 34969015)
16. Lue L. F., Kuo Y. M., Roher A. E., Brachova L., Shen Y., Sue L., Beach T., Kurth J. H., Rydel R. E., Rogers J., Soluble amyloid peptide concentration as a predictor of synaptic change in Alzheimer's disease American Journal of Pathology 1999 155 3 853 862 (Pubitemid 29426831)
17. Perlmutter L. S., Barron E., Chui H. C., Morphologic association between microGlia and senile plaque amyloid in Alzheimer's disease Neuroscience Letters 1990 119 1 32 36 (Pubitemid 20349720)
18. Paresce D. M., Ghosh R. N., Maxfield F. R., MicroGlial cells internalize aggregates of the Alzheimer's disease amyloid -protein via a scavenger receptor Neuron 1996 17 3 553 565 (Pubitemid 26322226)
19. Paresce D. M., Chung H., Maxfield F. R., Slow degradation of aggregates of the Alzheimer's disease amyloid -protein by microGlial cells Journal of Biological Chemistry 1997 272 46 29390 29397 (Pubitemid 27498234)
20. Takata K., Kitamura Y., Saeki M., Terada M., Kagitani S., Kitamura R., Fujikawa Y., Maelicke A., Tomimoto H., Taniguchi T., Shimohama S., Galantamine-induced amyloid- clearance mediated via stimulation of microGlial nicotinic acetylcholine receptors Journal of Biological Chemistry 2010 285 51 40180 40191
21. Takata K., Hirata-Fukae C., Becker A. G., Chishiro S., Gray A. J., Nishitomi K., Franz A. H., Sakaguchi G., Kato A., Mattson M. P., LaFerla F. M., Aisen P. S., Kitamura Y., Matsuoka Y., Deglycosylated anti-amyloid beta antibodies reduce microGlial phagocytosis and cytokine production while retaining the capacity to induce amyloid beta sequestration European Journal of Neuroscience 2007 26 9 2458 2468 (Pubitemid 350050431)
22. Takata K., Kitamura Y., Yanagisawa D., Morikawa S., Morita M., Inubushi T., Tsuchiya D., Chishiro S., Saeki M., Taniguchi T., Shimohama S., Tooyama I., MicroGlial transplantation increases amyloid- clearance in Alzheimer model rats FEBS Letters 2007 581 3 475 478 (Pubitemid 46149623)
23. Kitamura Y., Shibagaki K., Takata K., Tsuchiya D., Taniguchi T., Gebicke-Haerter P. J., Miki H., Takenawa T., Shimohama S., Involvement of Wiskott-Aldrich syndrome protein family verprolin-homologous protein (WAVE) and Rac1 in the phagocytosis of amyloid- (1-42) in rat microGlia Journal of Pharmacological Sciences 2003 92 2 115 123 (Pubitemid 36833457)
24. Takata K., Kitamura Y., Tsuchiya D., Kawasaki T., Taniguchi T., Shimohama S., Heat shock protein-90-induced microGlial clearance of exogenous amyloid- 1-42 in rat hippocampus in vivo Neuroscience Letters 2003 344 2 87 90 (Pubitemid 36628013)
25. Kakimura J. I., Kitamura Y., Takata K., Umeki M., Suzuki S., Shibagaki K., Taniguchi T., Nomura Y., Gebicke-Haerter P. J., Smith M. A., Perry G., Shimohama S., MicroGlial activation and amyloid- clearance induced by exogenous heat-shock proteins FASEB Journal 2002 16 6 601 603 (Pubitemid 44793415)
26. Streit W. J., Sammons N. W., Kuhns A. J., Sparks D. L., Dystrophic MicroGlia in the Aging Human Brain Glia 2004 45 2 208 212 (Pubitemid 38196997)
27. Hickman S. E., Allison E. K., El Khoury J., MicroGlial dysfunction and defective -amyloid clearance pathways in aging alzheimer's disease mice Journal of Neuroscience 2008 28 33 8354 8360
28. Mller S., Scaffidi P., Degryse B., Bonaldi T., Ronfani L., Agresti A., Beltrame M., Bianchi M. E., The double life of HMGB1 chromatin protein: architectural factor and extracellular signal EMBO Journal 2001 20 16 4337 4340 (Pubitemid 32772027)
29. Scaffidi P., Misteli T., Bianchi M. E., Release of chromatin protein HMGB1 by necrotic cells triggers inflammation Nature 2002 418 6894 191 195 (Pubitemid 34773774)
30. Park J. S., Svetkauskaite D., He Q., Kim J. Y., Strassheim D., Ishizaka A., Abraham E., Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein Journal of Biological Chemistry 2004 279 9 7370 7377 (Pubitemid 38294612)
31. Kokkola R., Andersson A., Mullins G., stberg T., Treutiger C. J., Arnold B., Nawroth P., Andersson U., Harris R. A., Harris H. E., RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages Scandinavian Journal of Immunology 2005 61 1 1 9 (Pubitemid 40188342)
32. Takata K., Kitamura Y., Tsuchiya D., Kawasaki T., Taniguchi T., Shimohama S., High mobility group box protein-1 inhibits microGlial A clearance and enhances A neurotoxicity Journal of Neuroscience Research 2004 78 6 880 891 (Pubitemid 39657575)
33. Takata K., Kitamura Y., Kakimura J. I., Shibagaki K., Tsuchiya D., Taniguchi T., Smith M. A., Perry G., Shimohama S., Role of high mobility group protein-1 (HMG1) in amyloid- homeostasis Biochemical and Biophysical Research Communications 2003 301 3 699 703 (Pubitemid 36268947)
34. Kitamura Y., Shimohama S., Kamoshima W., Ota T., Matsuoka Y., Nomura Y., Smith M. A., Perry G., Whitehouse P. J., Taniguchi T., Alteration of proteins regulating apoptosis, Bcl-2, Bcl-x, Bax, Bak, Bad, ICH-1 and CPP32, in Alzheimer's disease Brain Research 1998 780 2 260 269 (Pubitemid 28082914)
35. Games D., Adams D., Alessandrini R., Barbour R., Berthelette P., Blackwell C., Carr T., Clemens J., Donaldson T., Gillespie F., Guido T., Hagoplan S., Johnson-Wood K., Khan K., Lee M., Leibowitz P., Lieberburg I., Little S., Masliah E., Alzheimer-type neuropathology in transgenic mice overexpressing V717F -amyloid precursor protein Nature 1995 373 6514 523 527
36. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., Cole G., Correlative memory deficits, A elevation, and amyloid plaques in transgenic mice Science 1996 274 5284 99 102 (Pubitemid 26332733)
37. Holcomb L., Gordon M. N., Mcgowan E., Yu X., Benkovic S., Jantzen P., Wright K., Saad I., Mueller R., Morgan D., Sanders S., Zehr C., O'Campo K., Hardy J., Prada C. M., Eckman C., Younkin S., Hsiao K., Duff K., Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes Nature Medicine 1998 4 1 97 100 (Pubitemid 28133087)
38. Campion D., Dumanchin C., Hannequin D., Dubois B., Belliard S., Puel M., Thomas-Anterion C., Michon A., Martin C., Charbonnier F., Raux G., Camuzat A., Penet C., Mesnage V., Martinez M., Clerget-Darpoux F., Brice A., Frebourg T., Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum American Journal of Human Genetics 1999 65 3 664 670 (Pubitemid 30468710)
39. Mawuenyega K. G., Sigurdson W., Ovod V., Munsell L., Kasten T., Morris J. C., Yarasheski K. E., Bateman R. J., Decreased clearance of CNS -amyloid in Alzheimer's disease Science 2010 330 6012 1774
40. Simard A. R., Soulet D., Gowing G., Julien J. P., Rivest S., Bone marrow-derived microGlia play a critical role in restricting senile plaque formation in Alzheimer's disease Neuron 2006 49 4 489 502 (Pubitemid 43221886)
41. El Khoury J., Toft M., Hickman S. E., Means T. K., Terada K., Geula C., Luster A. D., Ccr2 deficiency impairs microGlial accumulation and accelerates progression of Alzheimer-like disease Nature Medicine 2007 13 4 432 438 (Pubitemid 46559828)
42. Boche D., Denham N., Holmes C., Nicoll J. A. R., Neuropathology after active A 42 immunotherapy: implications for Alzheimer's disease pathogenesis Acta Neuropathologica 2010 120 3 369 384
43. Nicolll J. A. R., Wilkinson D., Holmes C., Steart P., Markham H., Weller R. O., Neuropathology of human Alzheimer disease after immunization with amyloid- peptide: a case report Nature Medicine 2003 9 4 448 452 (Pubitemid 36460079)
44. Tjernberg L. O., Callaway D. J. E., Tjernberg A., Hahne S., Lilliehk C., Terenius L., Thyberg J., Nordstedt C., A molecular model of Alzheimer amyloid -peptide fibril formation Journal of Biological Chemistry 1999 274 18 12619 12625
45. Kallijrvi J., Haltia M., Baumann M. H., Amphoterin includes a sequence motif which is homologous to the Alzheimer's -amyloid peptide (A ), forms amyloid fibrils in vitro, and binds avidly to A Biochemistry 2001 40 34 10032 10037 (Pubitemid 32800110)
46. Iwata N., Higuchi M., Saido T. C., Metabolism of amyloid- peptide and Alzheimer's disease Pharmacology and Therapeutics 2005 108 2 129 148 (Pubitemid 41527082)
47. Qiu W. Q., Walsh D. M., Ye Z., Vekrellis K., Zhang J., Podlisny M. B., Rosner M. R., Safavi A., Hersh L. B., Selkoe D. J., Insulin-degrading enzyme regulates extracellular levels of amyloid -protein by degradation Journal of Biological Chemistry 1998 273 49 32730 32738 (Pubitemid 28557658)
48. Shimizu E., Kawahara K., Kajizono M., Sawada M., Nakayama H., IL-4-induced selective clearance of oligomeric -amyloid peptide 1-42 by rat primary type 2 microGlia Journal of Immunology 2008 181 9 6503 6513
49. Lue L. F., Walker D. G., Brachova L., Beach T. G., Rogers J., Schmidt A. M., Stern D. M., Yan S. D., Involvement of microGlial receptor for advanced glycation endproducts (RAGE)in Alzheimer's disease: identification of a cellular activation mechanism Experimental Neurology 2001 171 1 29 45 (Pubitemid 32848443)
50. Tahara K., Kim H. D., Jin J. J., Maxwell J. A., Li L., Fukuchi K. I., Role of toll-like receptor signalling in A uptake and clearance Brain 2006 129 11 3006 3019 (Pubitemid 44684521)
51. Takata K., Kitamura Y., Umeki M., Tsuchiya D., Kakimura J. I., Taniguchi T., Gebicke-Haerter P. J., Shimohama S., Possible involvement of small oligomers of amyloid- peptides in 15-deoxy-12,14 prostaglandin J2-sensitive microGlial activation Journal Pharmacological Sciences 2003 91 4 330 333 (Pubitemid 36581954)
52. Akiyama H., Mori H., Saido T., Kondo H., Ikeda K., McGeer P. L., Occurrence of the diffuse amyloid -protein (A ) deposits with numerous A -containing Glial cells in the cerebral cortex of patients with Alzheimer's disease Glia 1999 25 4 324 331 (Pubitemid 29083832)
53. Faraco G., Fossati S., Bianchi M. E., Patrone M., Pedrazzi M., Sparatore B., Moroni F., Chiarugi A., High mobility group box 1 protein is released by neural cells upon different stresses and worsens ischemic neurodegeneration in vitro and in vivo Journal of Neurochemistry 2007 103 2 590 603 (Pubitemid 47498027)
54. Lotze M. T., Tracey K. J., High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal Nature Reviews Immunology 2005 5 4 331 342 (Pubitemid 40516158)
55. Liu K., Mori S., Takahashi H. K., Tomono Y., Wake H., Kanke T., Sato Y., Hiraga N., Adachi N., Yoshino T., Nishibori M., Anti-high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats FASEB Journal 2007 21 14 3904 3916 (Pubitemid 350232348)
56. Ohnishi M., Katsuki H., Fukutomi C., Takahashi M., Motomura M., Fukunaga M., Matsuoka Y., Isohama Y., Izumi Y., Kume T., Inoue A., Akaike A., HMGB1 inhibitor glycyrrhizin attenuates intracerebral hemorrhage-induced injury in rats Neuropharmacology 2011 61 5-6 975 980